Auxly Cannabis Group Inc
TSX:XLY

Watchlist Manager
Auxly Cannabis Group Inc Logo
Auxly Cannabis Group Inc
TSX:XLY
Watchlist
Price: 0.155 CAD 3.33% Market Closed
Market Cap: 209m CAD

Relative Value

XLY doesn't have a meaningful market cap.

The Relative Value of one XLY stock under the Base Case scenario is 0.094 CAD. Compared to the current market price of 0.155 CAD, Auxly Cannabis Group Inc is Overvalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

XLY Relative Value
Base Case
0.094 CAD
Overvaluation 39%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
33
vs Industry
70
Median 3Y
0.4
Median 5Y
0.7
Industry
2.6
Forward
1.3
vs History
12
vs Industry
Median 3Y
-0.2
Median 5Y
-0.8
Industry
21.6
vs History
12
vs Industry
47
Median 3Y
3.5
Median 5Y
1.8
Industry
16.5
vs History
12
vs Industry
26
Median 3Y
-0.8
Median 5Y
-1.4
Industry
22.5
vs History
12
vs Industry
61
Median 3Y
0.4
Median 5Y
0.6
Industry
2.3
vs History
47
vs Industry
65
Median 3Y
1.1
Median 5Y
1.5
Industry
2.9
Forward
1.4
vs History
65
vs Industry
29
Median 3Y
2.9
Median 5Y
5.8
Industry
5.5
vs History
11
vs Industry
Median 3Y
-2.7
Median 5Y
-3.9
Industry
13
Forward
12.2
vs History
14
vs Industry
Median 3Y
-2
Median 5Y
-2.7
Industry
16.6
Forward
-33.7
vs History
22
vs Industry
45
Median 3Y
9.1
Median 5Y
3.7
Industry
15.8
vs History
15
vs Industry
34
Median 3Y
6.4
Median 5Y
-5
Industry
19.1
vs History
7
vs Industry
66
Median 3Y
0.5
Median 5Y
0.5
Industry
1.9

Multiples Across Competitors

XLY Competitors Multiples
Auxly Cannabis Group Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Auxly Cannabis Group Inc
TSX:XLY
209m CAD 1.4 4.6 6.4 9.1
US
Eli Lilly and Co
NYSE:LLY
971.9B USD 16.4 52.8 35.5 38
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
509.1B USD 5.5 20.3 16.6 21.5
CH
Roche Holding AG
SIX:ROG
252.3B CHF 4.1 26.8 11.5 13.4
UK
AstraZeneca PLC
LSE:AZN
208.5B GBP 4.8 29.7 108 158
CH
Novartis AG
SIX:NOVN
202.4B CHF 4.5 17.7 11.2 14.5
US
Merck & Co Inc
NYSE:MRK
249.5B USD 3.9 13.1 9.3 11.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.5 13.7 9.6 11.2
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
147B USD 2.3 15 7.6 10.4
P/E Multiple
Earnings Growth PEG
CA
Auxly Cannabis Group Inc
TSX:XLY
Average P/E: 21.5
4.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
52.8
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.3
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.8
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.7
38%
0.8
CH
Novartis AG
SIX:NOVN
17.7
17%
1
US
Merck & Co Inc
NYSE:MRK
13.1
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.7
4%
3.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
15
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Auxly Cannabis Group Inc
TSX:XLY
Average EV/EBITDA: 399.4
6.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.5
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.6
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.5
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108
10%
10.8
CH
Novartis AG
SIX:NOVN
11.2
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.3
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.6
2%
4.8
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
1%
7.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Auxly Cannabis Group Inc
TSX:XLY
Average EV/EBIT: 1 710.9
9.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.5
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.4
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158
23%
6.9
CH
Novartis AG
SIX:NOVN
14.5
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.1
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
11.2
1%
11.2
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.4
8%
1.3